Firefly Neuroscience utilizes the Evoke platform for assessments, while the company is listed on Nasdaq and Evoke has received FDA 510(k) clearance.
3 reports, 2 independent
Updated Fri 00:00
No new developments lately
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Firefly Neuroscience utilizes the Evoke platform for assessments, while the company is listed on Nasdaq and Evoke has received FDA 510(k) clearance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Firefly will introduce the FDA-cleared Monarch device to its network, which utilizes the Evoke platform for assessment.Sub-event
Firefly Neuroscience announced a partnership and achieved FDA clearance for its non-drug treatment.1 source
Firefly Neuroscience leverages Evoke platform for assessments; company listed on Nasdaq and Evoke is FDA 510(k)-cleared.1 source